Patents by Inventor Stephen A. Johnston

Stephen A. Johnston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthetic Antibodies
    Publication number: 20190194358
    Abstract: The present invention provides methods for synthetic antibodies, methods for making synthetic antibodies, methods for identifying ligands, and related methods and reagents.
    Type: Application
    Filed: November 21, 2018
    Publication date: June 27, 2019
    Applicant: Arizona Board of Regents on behalf of Arizona State University
    Inventors: Stephen A Johnston, Neal Woodbury, Christopher W. Diehnelt, Paul Belcher, Nidhi Gupta, Zhan-Gong Zhoa, Matthew Greving, Jack Emery
  • Synthetic antibodies
    Patent number: 9863938
    Abstract: Methods for synthetic antibodies, methods for making synthetic antibodies, methods for identifying ligands, and related methods and reagents.
    Type: Grant
    Filed: March 5, 2014
    Date of Patent: January 9, 2018
    Assignee: ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Stephen A Johnston, Neal Woodbury, John C Chaput, Christopher W Diehnelt, Hao Yan
  • MOBILE HOME CARE UNIT
    Publication number: 20160333569
    Abstract: Modular or temporary healthcare building units are provided that interconnect with a patient's home. In one embodiment, one of the modular or temporary units includes a fully-equipped ADA-compliant bathroom. In another embodiment, the modular or temporary unit is referred to as a flex unit and typically accommodates a hospital bed and other associated support structures and features for housing and accommodating a patient that is in a stage of recovery or rehabilitation or, in some cases, the flex unit is used for end-of-life care.
    Type: Application
    Filed: May 11, 2016
    Publication date: November 17, 2016
    Inventor: Stephen A. Johnston
  • Synthetic Antibodies
    Publication number: 20140221253
    Abstract: Methods for synthetic antibodies, methods for making synthetic antibodies, methods for identifying ligands, and related methods and reagents.
    Type: Application
    Filed: March 5, 2014
    Publication date: August 7, 2014
    Applicant: Arizona Board of Regents, a body corporate of the State of Arizona, acting for and on behalf of Ariz
    Inventors: Stephen A Johnston, Neal Woodbury, John C Chaput, Christopher W Diehnelt, Hao Yan
  • Identification and use of novopeptides for the treatment of cancer
    Patent number: 8796414
    Abstract: Disclosed are compositions relating to novopeptides identified by the presence of frameshift mutations in tumor genes previously not identified as being oncogenic. The disclosed peptides can be used in the disclosed methods for the treatment of cancer.
    Type: Grant
    Filed: March 21, 2011
    Date of Patent: August 5, 2014
    Inventor: Stephen A. Johnston
  • Synthetic Antibodies
    Publication number: 20140128280
    Abstract: The present invention provides methods for synthetic antibodies, methods for making synthetic antibodies, methods for identifying ligands, and related methods and reagents.
    Type: Application
    Filed: November 5, 2013
    Publication date: May 8, 2014
    Applicant: Arizona Board of Regents, a body corporate of the State of Arizona, acting for and on behaif of Ariz
    Inventors: Stephen A Johnston, Neal Woodbury, Christopher W. Diehnelt, Paul Belcher, Nidhi Gupta, Zhang-Gong Zhoa, Matthew Greving, Jack Emery
  • PEPTIDE LIGANDS
    Publication number: 20130224730
    Abstract: A method of solid phase selection of peptide ligands for target proteins is presented. 15-20mers or greater are addressed in a microarray, and the target protein and optional competitor bound thereto and binding compared. A specific signal for the target protein indicates that a peptide has strong affinity for the target. Ligands can be coupled to solid supports and used for affinity purification of the target proteins as well as detection and modulation of target proteins. Specific peptide ligands for immuno-purifying norovirus.
    Type: Application
    Filed: November 16, 2010
    Publication date: August 29, 2013
    Applicant: ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Stephen A. Johnston, Christopher Diehnelt, Paul Belcher, Charles J. Arntzen, Robert Sutherland
  • Immobilizing an entity in a desired orientation on a support material
    Patent number: 8481679
    Abstract: The present invention relates to the identification and selection of attachment molecules that attach/immobilize an entity having a detectable activity or property on a support in an orientation that provides a detectable activity or property, and to surfaces made of the attachment molecules.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: July 9, 2013
    Assignee: Arizona Board of Regents Acting on behalf of Arizona State University
    Inventors: Stephen A Johnston, Christopher W Diehnelt
  • Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of
    Patent number: 8435533
    Abstract: The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: May 7, 2013
    Assignees: Auburn University, Board of Regents, The University of Texas System
    Inventors: Stephen A. Johnston, Katherine Stemke-Hale, Kathryn F. Sykes, Bernhard Kaltenboeck
  • IDENTIFICATION AND USE OF NOVOPEPTIDES FOR THE TREATMENT OF CANCER
    Publication number: 20130072660
    Abstract: Disclosed are compositions relating to novopeptides identified by the presence of framshift mutations in tumor genes previously not identified as being oncogenic. The disclosed peptides can be used in the disclosed methods for the treatment of cancer.
    Type: Application
    Filed: March 21, 2011
    Publication date: March 21, 2013
    Applicant: ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Stephen A. JOHNSTON, Doug LAKE
  • Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of
    Patent number: 8298542
    Abstract: The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques.
    Type: Grant
    Filed: August 2, 2010
    Date of Patent: October 30, 2012
    Assignees: Auburn University, Board of Regents, The University of Texas System
    Inventors: Stephen A. Johnston, Katherine Stemke-Hale, Kathryn F. Sykes, Bernhard Kaltenboeck
  • SYNBODIES TO AKT1
    Publication number: 20120220540
    Abstract: The present application provides synbodies against AKT1 differing in amino acid sequence, conjugation chemistry, linker/scaffold, or adjunct moiety. The synbodies are useful for diagnosis and treatment of cancer and as research reagents.
    Type: Application
    Filed: March 1, 2012
    Publication date: August 30, 2012
    Applicant: ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Stephen A. Johnston, Christopher Diehnelt, Nidhi Gupta, Paul Belcher
  • Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia
    Patent number: 8206724
    Abstract: The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques.
    Type: Grant
    Filed: April 19, 2007
    Date of Patent: June 26, 2012
    Assignees: Auburn University, Board of Regents, The University of Texas System
    Inventors: Stephen A. Johnston, Katherine Stemke-Hale, Kathryn F. Sykes, Bernhard Kaltenboeck
  • Synthetic Antibodies
    Publication number: 20120065123
    Abstract: Methods for synthetic antibodies, methods for making synthetic antibodies, methods for identifying ligands, and related methods and reagents.
    Type: Application
    Filed: March 23, 2010
    Publication date: March 15, 2012
    Inventors: Stephen A. Johnston, Neal Woodbury, Christopher Diehnelt, Paul Belcher, Nidhi Gupta, Zhan-Gong Zhao, Matthew Greving, Jack Emery, Hao Yan, John Chaput
  • SYNTHETIC ANTIBODIES
    Publication number: 20120021967
    Abstract: The present invention provides methods for synthetic antibodies, methods for making synthetic antibodies, methods for identifying ligands, and related methods and reagents.
    Type: Application
    Filed: April 23, 2009
    Publication date: January 26, 2012
    Applicant: Arizona Board of Regents, A Body Corporate of the State Of Arizona Acting for and Behalf of Arizona
    Inventors: Stephen A. Johnston, Neal Woodbury, Christopher Diehnelt, Paul Belcher, Nidhi Gupta, Zhan-Gong Zhao, Matthew Greving, Jack Emery
  • Synthetic Antibodies
    Publication number: 20110143953
    Abstract: The present invention provides methods for synthetic antibodies, methods for making synthetic antibodies, methods for identifying ligands, and related methods and reagents.
    Type: Application
    Filed: October 16, 2007
    Publication date: June 16, 2011
    Inventors: Stephen A. Johnston, Neal Woodbury, John C. Chaput, Chris W. Diehnelt, Hao Yan
  • Methods and Compositions for Vaccination Comprising Nucleic Acid and/or Polypeptide Sequences of Chlamydia
    Publication number: 20100316662
    Abstract: The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques.
    Type: Application
    Filed: August 2, 2010
    Publication date: December 16, 2010
    Applicant: AUBURN UNIVERSITY
    Inventors: Stephen A. Johnston, Katherine Stemke-Hale, Kathryn F. Sykes, Bernhard Kaltenboeck
  • Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of
    Patent number: 7811592
    Abstract: The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques.
    Type: Grant
    Filed: December 17, 2001
    Date of Patent: October 12, 2010
    Assignees: Auburn University, Board of Regents, The University of Texas System
    Inventors: Stephen A. Johnston, Katherine Stemke-Hale, Kathryn F. Sykes, Bernhard Kaltenboeck
  • Immobilizing an Entity in a Desired Orientation on a Support Material
    Publication number: 20100248977
    Abstract: The present invention relates to the identification and selection of attachment molecules that attach/immobilize an entity having a detectable activity or property on a support in an orientation that provides a detectable activity or property, and to surfaces made of the attachment molecules.
    Type: Application
    Filed: September 19, 2008
    Publication date: September 30, 2010
    Applicant: Arizona Board of Regents acting for and on behalf of Arizona State University
    Inventors: Stephen A. Johnston, Chris W. Diehnelt
  • IDENTIFICATION AND USE OF NOVOPEPTIDES FOR THE TREATMENT OF CANCER
    Publication number: 20090186042
    Abstract: Disclosed are compositions relating to novopeptides identified by the presence of frameshift mutations in tumor genes previously not identified as being oncogenic. The disclosed peptides can be used in the disclosed methods for the treatment of cancer.
    Type: Application
    Filed: February 27, 2007
    Publication date: July 23, 2009
    Applicant: Arizona Board of Regents for and on Behalf of Arizona State University
    Inventors: Stephen A. Johnston, Doug Lake